{
    "ticker": "HYGI",
    "name": "Hygieia, Inc.",
    "description": "Hygieia, Inc. is an innovative healthcare technology company focused on revolutionizing diabetes management through its advanced digital health solutions. Founded in 2011, Hygieia aims to empower patients with Type 1 and Type 2 diabetes to better manage their condition using its proprietary AI-driven platform, which integrates insulin dosing, continuous glucose monitoring, and personalized coaching. The company\u2019s flagship product, the Insulin Dosing Decision Support System (IDSS), provides real-time guidance to both patients and healthcare providers, optimizing insulin therapy and improving overall health outcomes. Hygieia is committed to enhancing the quality of life for diabetes patients by utilizing cutting-edge technology to deliver actionable insights and support. The company also engages in continuous research and development to enhance its offerings and expand its impact in the diabetes care landscape. With a vision to create a future where diabetes management is seamless, Hygieia collaborates with healthcare professionals and organizations to foster a more integrated approach to diabetes care, ensuring that patients have access to the tools they need to thrive. As diabetes prevalence continues to rise globally, Hygieia\u2019s mission is to lead the charge in transforming diabetes management through technology and innovation.",
    "industry": [
        "Healthcare",
        "Medical Technology"
    ],
    "headquarters": "Reston, Virginia, USA",
    "founded": "2011",
    "website": "https://www.hygieia.com",
    "ceo": "Dr. S. R. G. K. K. Kalluri",
    "social_media": {
        "twitter": "https://twitter.com/HygieiaInc",
        "linkedin": "https://www.linkedin.com/company/hygieia-inc/"
    },
    "investor_relations": "https://www.hygieia.com/investor-relations",
    "key_executives": [
        {
            "name": "Dr. S. R. G. K. K. Kalluri",
            "position": "CEO"
        },
        {
            "name": "John Smith",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Diabetes Management Solutions",
            "products": [
                "Insulin Dosing Decision Support System (IDSS)"
            ]
        }
    ],
    "seo": {
        "meta_title": "Hygieia, Inc. | Innovative Diabetes Management Solutions",
        "meta_description": "Explore Hygieia, Inc., a leader in diabetes management technology. Discover our AI-driven solutions designed to empower diabetes patients and enhance health outcomes.",
        "keywords": [
            "Hygieia",
            "Diabetes Management",
            "Healthcare Technology",
            "Insulin Dosing",
            "Digital Health",
            "AI in Healthcare"
        ]
    },
    "faq": [
        {
            "question": "What is Hygieia known for?",
            "answer": "Hygieia is known for its innovative diabetes management solutions, particularly the Insulin Dosing Decision Support System (IDSS)."
        },
        {
            "question": "Who is the CEO of Hygieia?",
            "answer": "Dr. S. R. G. K. K. Kalluri is the CEO of Hygieia, Inc."
        },
        {
            "question": "Where is Hygieia headquartered?",
            "answer": "Hygieia is headquartered in Reston, Virginia, USA."
        },
        {
            "question": "What are Hygieia's main products?",
            "answer": "Hygieia's main product is the Insulin Dosing Decision Support System (IDSS), designed to assist with diabetes management."
        },
        {
            "question": "When was Hygieia founded?",
            "answer": "Hygieia was founded in 2011."
        }
    ],
    "competitors": [
        "AMGN",
        "LLY",
        "AZN",
        "BMY"
    ],
    "related_stocks": [
        "JNJ",
        "PFE",
        "MRK",
        "ABBV"
    ]
}